BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vavougios GD, Breza M, Mavridis T, Krogfelt KA. FYN, SARS-CoV-2, and IFITM3 in the neurobiology of Alzheimer's disease. Brain Disorders 2021;3:100022. [DOI: 10.1016/j.dscb.2021.100022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Olivera E, Sáez A, Carniglia L, Caruso C, Lasaga M, Durand D. Alzheimer's disease risk after COVID-19: a view from the perspective of the infectious hypothesis of neurodegeneration. Neural Regen Res 2023;18:1404-10. [PMID: 36571334 DOI: 10.4103/1673-5374.360273] [Reference Citation Analysis]
2 Al-Kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Ahmed EA, Batiha GE. SARS-COV-2 infection and Parkinson's disease: Possible links and perspectives. J Neurosci Res 2023. [PMID: 36717481 DOI: 10.1002/jnr.25171] [Reference Citation Analysis]
3 Vavougios GD, Zarogiannis SG, Gourgoulianis KI. Systems biology in COVID-19. Omics Approaches and Technologies in COVID-19 2023. [DOI: 10.1016/b978-0-323-91794-0.00022-6] [Reference Citation Analysis]
4 Wang Z, Zhan J, Gao H. Computer-aided drug design combined network pharmacology to explore anti-SARS-CoV-2 or anti-inflammatory targets and mechanisms of Qingfei Paidu Decoction for COVID-19. Front Immunol 2022;13:1015271. [PMID: 36618410 DOI: 10.3389/fimmu.2022.1015271] [Reference Citation Analysis]
5 Vavougios GD, de Erausquin GA, Snyder HM. Type I interferon signaling in SARS-CoV-2 associated neurocognitive disorder (SAND): Mapping host-virus interactions to an etiopathogenesis. Front Neurol 2022;13:1063298. [PMID: 36570454 DOI: 10.3389/fneur.2022.1063298] [Reference Citation Analysis]
6 Mysiris DS, Vavougios GD, Karamichali E, Papoutsopoulou S, Stavrou VT, Papayianni E, Boutlas S, Mavridis T, Foka P, Zarogiannis SG, Gourgoulianis K, Xiromerisiou G. Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis. IJMS 2022;23:9739. [DOI: 10.3390/ijms23179739] [Reference Citation Analysis]
7 Alegría-arcos M, Barbosa T, Sepúlveda F, Combariza G, González J, Gil C, Martínez A, Ramírez D. Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19. Front Pharmacol 2022;13:952192. [DOI: 10.3389/fphar.2022.952192] [Reference Citation Analysis]
8 Vavougios GD, Mavridis T, Artemiadis A, Krogfelt KA, Hadjigeorgiou G. Trained immunity in viral infections, Alzheimer's disease and multiple sclerosis: A convergence in type I interferon signalling and IFNβ-1a. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022. [DOI: 10.1016/j.bbadis.2022.166430] [Cited by in F6Publishing: 1] [Reference Citation Analysis]